Interim analysis of an open-label extension study of sustained release fampridine in patients with multiple sclerosis

被引：0
|
作者：
Goodman, A. D.
Brown, T.
Krupp, L.
Schapiro, R.
Marinucci, L.
Cohen, R.
Blight, A.
机构：
来源：
MULTIPLE SCLEROSIS | 2009年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [21] Open-label study of pirfenidone in patients with progressive forms of multiple sclerosis
    Bowen, JD
    Maravilla, K
    Margolin, SB
    MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (03) : 280 - 283
  • [22] Inosine in the treatment of Multiple Sclerosis: an open-label study in 32 patients
    Toncev, G
    Milicic, B
    Perovic, S
    Toncev, S
    Zlatic, G
    Knezcvic, Z
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S253 - S253
  • [23] Inosine in the treatment of multiple sclerosis: An open-label study in 32 patients
    Toncev, G
    Milicic, B
    Perovic, S
    Toncev, S
    Zlatic, G
    Knezeuic, Z
    NEUROLOGY, 2005, 64 (06) : A383 - A383
  • [24] Open-label extension patient retention rates with dalfampridine extended-release tablets in multiple sclerosis
    Schapiro, R.
    Bethoux, F.
    Brown, T.
    Williamson, L.
    Rabinowicz, A.
    Marinucci, L.
    Carrazana, E.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 477 - 477
  • [25] Final Data from Open-Label Extension Studies of Dalfampridine Extended Release Tablets in Multiple Sclerosis
    Goodman, Andrew
    Blight, Andrew
    NEUROLOGY, 2012, 78
  • [26] Teriflunomide in paediatric patients with relapsing multiple sclerosis: results from the open-label TERIKIDS extension
    Chitnis, T.
    Banwell, B.
    Kappos, L.
    Arnold, D.
    Gucuyener, K.
    Deiva, K.
    Saubadu, S.
    Hu, W.
    Benamor, M.
    Le-Halpere, A.
    Truffinet, P.
    Tardieu, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 65 - 65
  • [27] Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study
    Talbot, Jacob
    Lundell, Henrik
    Marstrand, Lisbet
    Madsen, Camilla Gobel
    Hansen, Malene Bredahl
    Siebner, Hartwig Roman
    Sellebjerg, Finn
    Chow, Helene Hojsgaard
    Sondergaard, Helle Bach
    Sorensen, Per Solberg
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [28] Dose comparison trial of sustained-release fampridine in multiple sclerosis
    Goodman, A. D.
    Brown, T. R.
    Cohen, J. A.
    Krupp, L. B.
    Schapiro, R.
    Schwid, S. R.
    Cohen, R.
    Marinucci, L. N.
    Blight, A. R.
    NEUROLOGY, 2008, 71 (15) : 1134 - 1141
  • [29] Steady-State Pharmacokinetics and Tolerability of Orally Administered Fampridine Sustained-Release 10-mg Tablets in Patients With Multiple Sclerosis: A 2-Week, Open-Label, Follow-Up Study
    Vollmer, Timothy
    Blight, Andrew R.
    Henney, Herbert R., III
    CLINICAL THERAPEUTICS, 2009, 31 (10) : 2215 - 2223
  • [30] Predictors of Relapse in Ozanimod-Treated Patients With Multiple Sclerosis: Ad Hoc Analysis From the Open-Label Extension DAYBREAK Study
    Coyle, Patricia
    Dunn, Jeffrey Dunn Jeffrey
    Kappos, Ludwig
    Cheng, Chun-Yen
    Thorpe, Andrew
    Morello, Jean Pierre
    Silva, Diego
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 957 - 958
12345